Find
Home
Clinical Trials
Symptom Management
Videos
OncUTube Home
Continuing Education
Calendar
Links
You are here:
Videos
Register
|
Login
Install latest flash player if this video gallery doesn't work.
SHARE THIS VIDEO
Everolimus + Octreotide LAR in Patients With Advanced Lung NETs: Analysis From RADIANT-2
Dr. Ashley Grossman reviews this exploratory subgroup analysis of the Radiant-2 study, in patients with primary tumor site in the lung. This analysis was presented at the recent European Multidisciplinary Cancer Congress 23 - 27 September 2011.
European Multidisciplinary Cancer Congress
Effect of Everolimus Plus Octreotide LAR in Patients With Advanced Lung Neuroendocrine Tumors: Analysis From RADIANT-2
Recent Video
|
Most Viewed
Tumor Type :
<All Tumor Types>
Advocacy Group Interviews
Brain Cancer
Breast Cancer
Clinical Trial Cooperative Groups
Colorectal Cancer
Gastric Cancer
Gastrointestinal Stromal Tumor (GIST) Cancer
General Educational Topics
Head and Neck Cancer
Headline News
Leukemia
Lung Cancer
Lymphoma
Melanoma
Myeloma
Myeloproliferative Neoplasms (MPN)
Neuroendocrine Tumors (NET)
Oncology Nursing Society
Ovarian Cancer
Pancreatic Cancer
Pediatric Oncology
Prostate Cancer
Renal Cell Carcinoma (Kidney) Cancer
Sarcomas
Supportive Care
Symptom Management
Technology and Medicine
Thyroid Cancer
Search :
Recipient of the CURE Magazine Extraordinary...
02:22
Headline News in Ovarian Cancer - 2012 ASCO
03:22
Headline News in Kidney Cancer - 2012 ASCO
02:21
Headline News in Prostate Cancer - 2012 ASCO
03:35
Headline News in Lung Cancer - ASCO 2012
07:30
Headline News in Breast Cancer - 2012 ASCO
06:42
Ganetespib - interview with Vojo Vukovic, MD...
03:06
Breast Cancer and 2012 ASCO Merit Award Winn...
03:58
Evaluation of MET pathway in biomarkers in a...
03:09
The Cutaneous Lymphoma Foundation - intervie...
07:19
Ganetespib - interview with Suresh Ramalinga...
05:36
Lung cancer(s) treatment - interview with Ro...
05:11
Molecular Profiling - interview with Sandeep...
06:13
Journal of Bone Oncology - interview with Pr...
04:50
NSCLC and the ARCHER Trial - interview with ...
03:46
The Triple Negative Breast Cancer Foundation...
11:15
Prostate Cancer and OGX 427 - interview with...
06:07
Current Treatment Landscape in Melanoma - in...
04:36
Lung Cancer - interview with Geoff Oxnard, M...
07:37
Breast Cancer - interview with Elizabeth Ann...
07:30
Treatment for gynecologic cancers - intervie...
07:02
Tumor Treating Fields: The Fourth Treatment ...
05:26
2012 ASCO Humanitarian Award Winner - interv...
07:54
Kidney Cancer Treatment and Unmet Needs - in...
06:41
Kidney Cancer - interview with Brian Rini, M...
03:03
Colorectal Cancer and the CORRECT Trial - in...
08:35
CINV - Chemotherapy-induced Nausea and Vomit...
06:13
CINV - Chemotherapy-induced Nausea and Vomit...
05:08
Stacey Lewis, Chief Program Officer and Depu...
02:22
Is My Cancer Different.com - Roberta Smigel
02:09
Recipient of the Pearl Moore Award - Pat Fra...
05:46
National Coalition For Cancer Survivorship -...
07:31
New Developments in the Field of Colorectal ...
02:18
Everolimus in Postmenopausal Hormone-Recepto...
03:51
On Being a Clinical Trials Nurse - Laura Woo...
05:02
Fight Colorectal Cancer - Kim Ryan
04:34
Penns Wood Chapter of the ONS - Joy Hepkins,...
06:08
Outpatient Infusion Systems Paperless Initia...
02:13
The International Society of Nurses in Cance...
02:17
Promoting a Healthy Work Environment For Nur...
04:48
Decision to Treat Advanced Malignancies — in...
05:02
Acute Myeloid Leukemia (AML) — interview wit...
02:45
Bosutinib Versus Imatinib (CML) Follow-up St...
05:22
Update on JAK Inhibitor — COMFORT II Trial i...
06:50
Update on JAK Inhibitor — Spleen Volume Redu...
10:20
Asparaginase as a Treatment in Acute Lymphob...
07:19
NTDT, or Non–transfusion-dependent Thalassem...
06:33
Brentuximab Vedotin in T-Cell Lymphoma — int...
05:21
Multiple Myeloma — interview with David H. V...
05:10
Personalized Medicine, Genomics and Biomarke...
05:33
Leucovorin Rescue in Managing Recurrent Pral...
08:00
Chronic Myeloid Leukemia (CML) Update — inte...
04:21
High Expression of CRBN That Is Associated W...
03:29
Robert Rosen, Chairman of the MPN Research F...
04:06
Ravindra Sarode, MD, and President-Elect of ...
03:24
Nilotinib Versus Imatinib in Patients With N...
04:46
Effect of Everolimus on Markers of Angiogene...
07:47
Updated Survival and Safety Data From RADIAN...
07:32
Everolimus + Octreotide LAR in Patients With...
08:00
Colon and Rectal Cancer: A Racial Divide
23:21
Overview of the COMFORT II trial and discuss...
07:58
COMFORT II Discussion with Dr. Claire Harris...
05:45
COMFORT II - Why is spleen volume so importa...
05:29
COMFORT II Additional Data Discussion with D...
01:35
What do the results of the COMFORT I and II ...
02:43
TIVO-1, Phase 3 Study in Advanced Kidney Can...
05:45
Evaluation of BCR-ABL monitoring in Chronic ...
04:04
An interview Andrew Spiegel, CEO and Co-Foun...
03:01
Correlation of Treatment-emergent Adverse Ev...
03:24
Colon Cancer and Patient Compliance
02:49
What is Familial Adenomatous Polyposis or FA...
04:00
My Cancer Advisor
01:25
The Patient Resource Cancer Guide
03:13
Kidney Cancer Association – We’re Here to He...
06:13
Disparities in Colon Cancer Rates Afflictin...
05:20
Integrative Medicine: Vitamin C’s Positive E...
09:24
Genetics and Cancer, a Current Neo-Adjuvant ...
04:27
Overview of the Melanoma Research Foundation...
04:33
Stage III-IV Head and Neck Squamous Cell Car...
09:15
Healthy and Fit After Cancer – Optimal heal...
04:34
YES ! – Beat Liver Tumors
01:23
Volontie 1 Foundation - Rehabilitating Cance...
03:03
Benefit of Denosumab Therapy in Patients Wit...
04:27
A Phase II Study of Low-dose Protracted Irin...
04:15
Updated Overall Survival and PFS by Blinded ...
05:08
Progression-Free Survival from a Phase 1 Stu...
03:20
Acral Lentiginous Melanoma in Hawaii: Charac...
02:24
Phase II Trial of Neoadjuvant/Adjuvant Imati...
03:06
24 Months Follow-Up From the Patient’s Anast...
03:25
Surviving Childhood Cancer – What Next? Cha...
04:36
The Turkish Pediatric Oncology Society
06:40
Second Malignant Tumors in Childhood Cancer ...
06:33
Denosumab vs. Zoledronic Acid in Patients wi...
05:57
Identification of Pre- and Post-Treatment Ma...
03:48
Advances in Immunotherapy and Melanoma
02:38
The Cholangiocarcinoma Foundation
05:03
Study Finds Vaccine Extends Recurrent GBM Su...
04:14
Phase II study of the Hsp90 inhibitor ganete...
08:13
Ganetespib (STA-9090) as Monotherapy in Pati...
03:39
Overview of the Cutaneous Lymphoma Foundatio...
04:39
RSS this page
Advertise on OncUView.tv
Privacy Statement
|
Terms Of Use
|
Copyright 2010-2013 by OncUView.tv, LLC